Results 201 to 210 of about 917,694 (267)

Artificial Intelligence and the Transformation of Cell and Gene Therapy Development. [PDF]

open access: yesPharmaceutics
Auclair JR   +4 more
europepmc   +1 more source

Integration of Digital Twin Technology in Orthodontics: A Scoping Review. [PDF]

open access: yesInt J Dent
Bhardwaj I   +5 more
europepmc   +1 more source

Scoping review of e-cigarette use in the perioperative setting: a protocol. [PDF]

open access: yesBMJ Open
Harrogate SR   +4 more
europepmc   +1 more source

Nanoamorphous drug products – Design and development

International Journal of Pharmaceutics, 2018
Most of the recent drug compounds coming out of the drug discovery pipeline are labile (multiple polymorphs), and need to be developed into robust marketed oral drug formulations. There are only 22 oral macroamorphous drug products approved by FDA and till date none approved oral nanoamorphous drug products.
Rajan, Jog, Diane J, Burgess
openaire   +2 more sources

Designing a Family of Development-Intensive Products

Management Science, 2006
Faced with fragmented markets, saturated and demanding customers, and global competition, firms increasingly must design and offer a line of innovative, quality-differentiated products to target customers with differing willingness to pay (WTP). In this context, designing a special class of products that we term development-intensive products (DIPs ...
V. Krishnan, W. Zhu
openaire   +1 more source

Home - About - Disclaimer - Privacy